Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 36Lung Neoplasms 7Brain Neoplasms 3Thyroid Neoplasms 2Neoplasms 2Gastrointestinal Neoplasms 2Breast Neoplasms 2Thyroid Cancer, Papillary 1Thoracic Neoplasms 1Sexual Dysfunction, Physiological 1Sarcoma 1Salivary Gland Neoplasms 1Respiratory Tract Neoplasms 1Respiratory Tract Diseases 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neuroendocrine Tumors 1Neoplasms by Site 1Multiple Endocrine Neoplasia Type 2a 1Melanoma 1Lymphoma, Large-Cell, Anaplastic 1Lung Diseases 1Intestinal Neoplasms 1Intestinal Diseases 1Head and Neck Neoplasms 1Genomic Instability 1Gastrointestinal Diseases 1Eunuchism 1Erectile Dysfunction 1Disease Resistance 1

Interventions

alectinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Disease Resistance × alectinib × Thoracic × Clear all
NCT04708639 2021-02-02

MonAlec

Aarhus University Hospital

Unknown
40 enrolled
Thoracic

Lung Neoplasms, Disease Resistance

Data powered by HemOnc (CC BY 4.0) Colophon âš¡